Krystal Biotech, Inc. Cash Flow Statement

Cash Flow Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -32.17M-69.57M-139.97M10.93M89.16M
Depreciation and Depletion 0.00M0.02M0.14M0.75M1.50M1.85M2.64M5.01M6.00M
Share-based Compensation 0.03M0.25M0.79M1.24M3.27M15.32M33.23M39.93M49.13M
Gains from Investment Securities 3.07M0.93M4.40M1.56M5.09M6.07M
Cash from Operations -1.31M-3.89M-9.45M-18.69M-26.08M-47.94M-100.57M-88.80M123.42M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.23M0.92M0.74M0.90M0.75M
Amortization of Deferred Charges 0.01M3.26M
Depreciation & Amortization (CF) 0.00M0.02M0.14M1.09M1.85M2.77M4.05M5.01M6.00M
Change in Working Capital
Change in Receivables 42.04M62.71M
Change in Inventory 4.47M11.91M
Change in Account Payables 0.04M0.13M0.11M-0.20M0.78M0.71M-1.25M-0.10M1.01M
Change in Accured Expenses 0.00M0.44M0.64M0.55M2.31M2.71M5.17M4.56M5.39M
Other Working Capital Changes 0.25M0.08M0.32M0.87M1.92M0.69M0.61M1.61M8.91M
Investing Activities
Capital Expenditures 0.01M0.21M2.23M6.40M14.84M68.34M52.98M11.80M8.50M
Change in Intangibles 100.00M
Change in Acquisitions & Divestments 10.50M6.87M32.03M257.68M503.21M298.54M
Cash from Investing Activities -0.01M-0.21M-10.32M-4.99M-11.18M-226.77M-114.08M82.64M-163.44M
Financing Activities
Cash from Financing Activities 3.25M51.77M73.85M107.53M118.02M347.69M35.35M202.75M27.01M
Additional items
Exchange Rate Effect -0.04M-0.16M-0.46M
Change in Cash 1.92M47.67M54.08M83.84M80.75M72.98M-179.35M196.43M-13.46M
Free Cash Flow -1.33M-4.10M-11.68M-25.09M-40.93M-116.27M-153.55M-100.60M114.92M
Net Cash Flow 1.92M47.67M54.08M83.84M80.75M72.98M-179.31M196.58M-13.01M